Krystal Biotech Inc (KRYS)
170.85
-5.54
(-3.14%)
USD |
NASDAQ |
Nov 04, 16:00
171.06
+0.21
(+0.12%)
After-Hours: 20:00
Krystal Biotech Profit Margin (Quarterly): 22.15% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 22.15% |
| March 31, 2024 | 2.06% |
| Date | Value |
|---|---|
| December 31, 2023 | 20.62% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
2.06%
Minimum
Mar 2024
22.15%
Maximum
Jun 2024
14.94%
Average
20.62%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Bioventus Inc | -15.87% |
| ADMA Biologics Inc | 29.91% |
| Axsome Therapeutics Inc | -91.03% |
| Amicus Therapeutics Inc | -12.39% |
| Sarepta Therapeutics Inc | 1.78% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 13.85% |
| Return on Assets | 12.54% |
| Return on Invested Capital | 13.36% |
| Gross Profit Margin (Quarterly) | 91.45% |
| Operating Margin (Quarterly) | 29.97% |
| Return on Net Operating Assets | 46.64% |